Functional Neurological Disorder (FND) involves neurological symptoms arising from brain network changes rather than structural damage, often described as a “software” issue rather than a “hardware” problem. Symptoms…
Pompe disease is a progressive, life-threatening genetic neuromuscular disorder. Late-onset Pompe disease (LOPD), affecting individuals over one year old, leads to trunk and proximal muscle weakness, often impacting…
With over 5 million people suffering from Alzheimer’s disease in the United States, finding viable treatments has become a top priority. However, only four drugs targeting this disease…
An increasing number of manufacturers are entering the robotic surgery space. There were over half of a million robot-assisted surgeries in both 2014 and 2015, and that number…
Spinal muscular atrophy (SMA) is one of 7,000 rare diseases. It is the second-most common autosomal recessive disease in humans and the number one genetic cause of death…
Neuroreader is a neuroimaging software tool that creates accurate structural MRI assessments in under 5 minutes. The software provides valuable information for the diagnosis and treatment of persons…
There have been many advancements in chemotherapy and immunotherapy treatments for various cancers over the past decade, but the 5-year relative survival rate for glioblastoma patients is still…
Using a motor cortex implant, a series of electrode-lined bracelets, and sophisticated software, this paralyzed patient temporarily regained some use of his wrists and hands.
Neuroreader™ is an advanced piece of software that analyzes data from a patient’s structural MRI scan, measures 45 different brain structures (two-dozen more than any current competing software),…
